2013

• McCaughan, G., Blinman, P., Boyer, M., Stockler, M. (2013), Better estimates of survival for patients considering adjuvant chemotherapy after surgery for early non-small cell lung cancer. Internal Medicine Journal. 43(4), 424-429. [Abstract]

2012

• Yeo, W., Chung, H., Chan, S., Wang, L., Lim, R., Picus, J., Boyer, M., Mo, F., Koh, J., Rha, S., Hui, E., Jeung, H., Roh, J., Yu, S., To, K., Tao, Q., Ma, B., Chan, A., Tong, J., Erlichman, C., Chan, A., Goh, B. (2012), Epigenetic Therapy Using Belinostat for Patients With Unresectable Hepatocellular Carcinoma: A Multicenter Phase I/II Study With Biomarker and Pharmacokinetic Analysis of Tumors From Patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group. Journal of Clinical Oncology. 30(27), 3361-3367. [Abstract]
• Ramalingam, S., Blackhall, F., Krzakowski, M., Barrios, C., Park, K., Bover, I., Seog Heo, D., Rosell, R., Talbot, D., Frank, R., Letrent, S., Ruiz-Garcia, A., Taylor, I., Liang, J., Campbell, A., O'Connell, J., Boyer, M. (2012), Randomized Phase II Study of Dacomitinib (PF-00299804), an Irreversible Pan-Human Epidermal Growth Factor Receptor Inhibitor, Versus Erlotinib in Patients With Advanced Non-Small-Cell Lung Cancer. Journal of Clinical Oncology. 30(27), 3337-3344. [Abstract]
• Sundaresan, P., Hruby, G., Hamilton, A., Hong, A., Boyer, M., Chatfield, M., Thompson, J. (2012), Definitive Radiotherapy or Chemoradiotherapy in the Treatment of Merkel Cell Carcinoma. Clinical Oncology. 24(9), e131-e136. [Abstract]
• Boyer, M., Horwood, K., Pavlakis, N., DE Souza, P., Millward, M., Stein, B., Johnston, M., Abell, F., Rischin, D. (2012), Efficacy of erlotinib in patients with advanced Non-small-cell Lung Cancer (NSCLC): Analysis of the Australian subpopulation of the TRUST study. Asia-Pacific Journal of Clinical Oncology. 8(3), 248-254. [Abstract]
• Kim, G., Mahoney, M., Szydlo, D., Mok, T., Marshke, R., Holen, K., Picus, J., Boyer, M., Pitot, H., Rubin, J., Philip, P., Nowak, A., Wright, J., Erlichman, C. (2012), An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinoma. Investigational New Drugs. 30(1), 387-394. [Abstract]
• Dhillon, H., van der Ploeg, H., Bell, M., Boyer, M., Clarke, S., Vardy, J. (2012), The impact of physical activity on fatigue and quality of life in lung cancer patients: a randomised controlled trial protocol. BMC Cancer. 12, 572. [Abstract]
• Yip, P., Barnes, D., McCaughan, B., Boyer, M. (2012), Diagnosis and treatment of lung cancer: A focus on the GP's role. Medicine Today. 13(2), 30-36.

2011

• Vansteenkiste, J., Solomon, B., Boyer, M., Wolf, J., Miller, N., Di Scala, L., Pylvaenaeinen, I., Petrovic, K., Dimitrijevic, S., Anrys, B., Laack, E. (2011), Everolimus in Combination with Pemetrexed in Patients with Advanced Non-small Cell Lung Cancer Previously Treated with Chemotherapy: A Phase I Study Using a Novel, Adaptive Bayesian Dose-Escalation Model. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 6(12), 2120-9. [Abstract]
• Hirsh, V., Paz-Ares, L., Boyer, M., Rosell, R., Middleton, G., Eberhardt, W., Szczesna, A., Reiterer, P., Saleh, M., Arrieta, O., Bajetta, E., Webb, R., Raats, J., Benner, R., Fowst, C., Meech, S., Readett, D., Schiller, J. (2011), Randomized Phase III Trial of Paclitaxel/Carboplatin With or Without PF-3512676 (Toll-Like Receptor 9 Agonist) As First-Line Treatment for Advanced Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(19), 2667-74. [Abstract]
• Cooper, W., O'toole, S., Boyer, M., Horvath, L., Mahar, A. (2011), What's new in non-small cell lung cancer for pathologists: the importance of accurate subtyping, EGFR mutations and ALK rearrangements. Pathology. 43(2), 103-115. [Abstract]
• Cox, K., Goel, S., O'Connell, R., Boyer, M., Beale, P., Simes, R., Stockler, M. (2011), A randomised crossover trial comparing inpatient and outpatient administration of high dose cisplatin. Internal medicine journal. (2). [Abstract]
• Yan, T., Cao, C., Boyer, M., Tin, M., Kennedy, C., McLean, J., Bannon, P., McCaughan, B. (2011), Improving survival results after surgical management of malignant pleural mesothelioma: an Australian institution experience. Annals of Thoracic and Cardiovascular Surgery. 17(3), 243-249. [Abstract]

2010

• Kao, S., Pavlakis, N., Harvie, R., Vardy, J., Boyer, M., van Zandwijk, N., Clarke, S. (2010), High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clinical Cancer Research. 16(23), 5805-5813. [Abstract]
• Moore, M., Stockler, M., Lim, R., Mok, T., Millward, M., Boyer, M. (2010), A phase II study of fenretinide in patients with hormone refractory prostate cancer: a trial of the Cancer Therapeutics Research Group. Cancer chemotherapy and pharmacology. 66(5), 845-50. [Abstract]
• Grimison, P., Stockler, M., Thomson, D., Olver, I., Harvey, V., Gebski, V., Lewis, C., Levi, J., Boyer, M., Gurney, H., Craft, P., Boland, A., Simes, R., Toner, G. (2010), Comparison of Two Standard Chemotherapy Regimens for Good-Prognosis Germ Cell Tumors: Updated Analysis of a Randomized Trial. Journal of the National Cancer Institute. 102(16), 1253-62. [Abstract]
• Kao, S., McCaughan, B., Muljono, A., Boyer, M. (2010), A pathological complete response in malignant pleural mesothelioma after combination chemotherapy with Carboplatin and pemetrexed. Journal of Thoracic Oncology. 5(3), 405-406. [Abstract]
• Oh, B., Butow, P., Mullan, B., Clarke, S., Tattersall, M., Boyer, M., Beale, P., Vardy, J., Pavlakis, N., Larke, L. (2010), Patient-doctor communication: use of complementary and alternative medicine by adult patients with cancer. Journal of the Society for Integrative Oncology. 8(2), 56-64. [Abstract]

2009

• Soon, Y., Stockler, M., Askie, L., Boyer, M. (2009), Reply to A.D. Sasse et al. Journal of Clinical Oncology. 27(35), e254. [Abstract]
• Zhao, L., Lee, B., Brown, D., Molloy, M., Marx, G., Pavlakis, N., Boyer, M., Stockler, M., Kaplan, W., Breit, S., Sutherland, R., Henshall, S., Horvath, L. (2009), Identification of candidate biomarkers of therapeutic response to docetaxel by proteomic profiling. Cancer Research. 69(19), 7696-7703. [Abstract]
• Yan, T., Boyer, M., Tin, M., Wong, D., Kennedy, C., McLean, J., Bannon, P., McCaughan, B. (2009), Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors. The Journal of Thoracic and Cardiovascular Surgery. 138(3), 619-624. [Abstract]
• Tattersall, M., Dear, R., Jansen, J., Shepherd, H., J Devine, R., G Horvath, L., Boyer, M. (2009), Second opinions in oncology: the experiences of patients attending the Sydney Cancer Centre. Medical Journal of Australia. 191(4), 209-212. [Abstract]
• Pezaro, C., Rosenthal, M., Gurney, H., Davis, I., Underhill, C., Boyer, M., Kotasek, D., Solomon, B., Toner, G. (2009), An Open-Label, Single-Arm Phase Two Trial of Gefitinib in Patients With Advanced or Metastatic Castration-Resistant Prostate Cancer. American journal of clinical oncology. 32(4), 338-41. [Abstract]
• Soon, Y., Stockler, M., Askie, L., Boyer, M. (2009), Duration of Chemotherapy for Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(20), 3277-83. [Abstract]
• Simonella, L., O'Connell, D., Vinod, S., Delaney, G., Boyer, M., Esmaili, N., Hensley, M., Goldsbury, D., Supramaniam, R., Hui, A., Armstrong, B. (2009), No improvement in lung cancer care: The management of lung cancer in 1996 and 2002 in New South Wales. Internal medicine journal. 39(0), 453-8. [Abstract]
• Yan, T., Boyer, M., Tin, M., Sim, J., Kennedy, C., McLean, J., Bannon, P., McCaughan, B. (2009), Prognostic features of long-term survivors after surgical management of malignant pleural mesothelioma. The Annals of Thoracic Surgery. 87(5), 1552-1556. [Abstract]
• Martin, R., Fulham, M., Shannon, K., Hughes, C., Gao, K., Milross, C., Tin, M., Jackson, M., Clifford, A., Boyer, M., O'Brien, C. (2009), Accuracy of positron emission tomography in the evaluation of patients treated with chemoradiotherapy for mucosal head and neck cancer. Head & neck. 31(0), 244-50. [Abstract]
• Yan, T., Tin, M., Boyer, M., McLean, J., Bannon, P., McCaughan, B. (2009), Treatment Failure after Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma. Journal of Thoracic Disease,. 1(1), 23-28.
• Vardy, J., Dadasovich, R., Beale, P., Boyer, M., Clarke, S. (2009), Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials. BMC cancer. 9(1), 130. [Abstract]

2008

• Vinod, S., O'Connell, D., Simonella, L., Delaney, G., Boyer, M., Peters, M., Miller, D., Supramaniam, R., McCawley, L., Armstrong, B. (2008), Gaps in optimal care for lung cancer. Journal of Thoracic Oncology. 3(8), 871-879. [Abstract]
• Kenny, P., King, M., Viney, R., Boyer, M., Pollicino, C., McLean, J., Fulham, M., McCaughan, B. (2008), Quality of life and survival in the 2 years after surgery for non small-cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(2), 233-241. [Abstract]

2007

• Oates, J., Clark, J., Read, J., Reeves, N., Gao, K., Jackson, M., Boyer, M., O'brien, C. (2007), Prospective evaluation of quality of life and nutrition before and after treatment for nasopharyngeal carcinoma. Archives of otolaryngology--head & neck surgery. 133(6), 533-540. [Abstract]
• Yeo, W., Boyer, M., Chung, H., Ong, S., Lim, R., Zee, B., Ma, B., Lam, K., Mo, F., Ng, E., Ho, R., Clarke, S., Roh, J., Beale, P., Rha, S., Jeung, H., Soo, R., Goh, B., Chan, A. (2007), Irofulven as first line therapy in recurrent or metastatic gastric cancer: a phase II multicenter study by the Cancer Therapeutics Research Group (CTRG). Cancer chemotherapy and pharmacology. 59(3), 295-300. [Abstract]
• Chuah, B., Lim, R., Boyer, M., Ong, A., Wong, S., Kong, H., Millward, M., Clarke, S., Goh, B. (2007), Multi-centre phase II trial of Thalidomide in the treatment of unresectable hepatocellular carcinoma. Acta oncologica. 46(2), 234-238. [Abstract]
• Miller, D., Boyer, M., Supramaniam, R., Armstrong, B., Simonella, L., OConnell, D., Vinod, S., McCawley, L., Delaney, G. (2007), Patterns of lung cancer care in NSW, Australia. JOURNAL OF THORACIC ONCOLOGY. 2, S351-S351. [Abstract]
• Goldstein, D., Yuen, J., Dhillon, H., Della-Fiorentina, S., Hargreaves, C., Truskett, P., Johnston, P., Richardson, G., Archer, S., Trotter, J., Cullingford, G., Gebski, V., Storey, D., Findlay, M., Boyer, M., Davidson, A. (2007), A pilot study of preoperative and postoperative chemotherapy in patients with operable gastric cancer: Australasian Gastrointestinal Trials Group study 9601. ANZ Journal Of Surgery. 77(4), 247-252. [Abstract]